lifestyle.timesla.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
GC Corp.
GC Biopharma Receives Marketing Authorization for Varicella Vaccine ‘BARYCELA Inj.’ in Guatemala
March 26, 2026
GCCL Showcases RSV FRNT Research and Integrated Bioanalytical Capabilities at World Vaccine Congress 2026
March 24, 2026
GC Biopharma Publishes a Comprehensive Review Paper Summarizing 30 Years of Accumulated Data on Its Proprietary Varicella Vaccine Strain, ‘MAV/06’
March 11, 2026
GCCL and Medicover Integrated Clinical Services Announce Strategic Collaboration to Strengthen Multinational Clinical Trial Services
February 12, 2026
GCCL and OPIS Announce Strategic Collaboration to Advance Global Clinical Trial Capabilities
January 15, 2026
GC Biopharma Secures IND Approval for Phase 1 Clinical Trial of COVID-19 mRNA Vaccine in Korea
January 6, 2026
GC Biopharma Ships First Doses of World’s First Recombinant Anthrax Vaccine, ‘BARYTHRAX inj.’
December 15, 2025
GC Biopharma’s Varicella Vaccine Strain ‘MAV/06’ Listed in WHO Position Paper
December 9, 2025
GC Genome Study Identifies ‘Confounders’ Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy
December 9, 2025
GC Genome Publishes Blood-Based Colorectal Cancer Screening Study in the American Journal of Gastroenterology
November 28, 2025
1
2
Next Page
→